|
Abstract:
|
Concerns have been raised that Medicare quality measurement and payment programs that do not account for social risk factors, particularly value-based payment programs, may underestimate the quality of care provided by health systems that disproportionately serve socially at-risk populations. A National Academy of Medicine committee recently issued a series of reports that examined the conceptual basis, methods and data sources that CMS might rely on for such adjustment. Dr. Rosenthal, a member of the NAM committee, will discuss the committee's findings and their potential application to Medicare value-based purchasing models.
|
